Atara Biotherapeutics ATRA
NASDAQ ATRA
$9.43 +0.08 (+0.86%)
At close: Oct 22, 2026 · 4:00 PM EDT

Atara Biotherapeutics (ATRA) Net Preferred Shares Issued and Repurchased (2013 - 2014)

Updated

Analysis

Atara Biotherapeutics (ATRA) Net Preferred Shares Issued and Repurchased (2013 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,140.91 Bn 1,109.50 Bn 19.71 Bn -
2 Johnson & Johnson 634.46 Bn 554.32 Bn 17.30 Bn -
3 AbbVie 500.42 Bn 473.54 Bn 12.70 Bn -
4 Merck 355.19 Bn 309.56 Bn 12.21 Bn -
5 Novartis Ag 300.18 Bn 264.17 Bn 11.24 Bn -
6 Astrazeneca 263.17 Bn 236.86 Bn 12.86 Bn -
7 Amgen 237.83 Bn 193.23 Bn 7.24 Bn -
8 Gilead Sciences 193.81 Bn 168.01 Bn 6.22 Bn -
9 Pfizer 170.12 Bn 116.76 Bn 10.94 Bn -
10 Atara Biotherapeutics 137.78 Mn 127.88 Mn 439,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -19,000.00
Mar 31, 2014 13.50 Mn
Dec 31, 2013 38.29 Mn
API Access

Atara Biotherapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=ATRA&period=max&api_key=YOUR_API_KEY